4.6667
Atai Life Sciences N V Borsa (ATAI) Ultime notizie
Apeiron Investment Group Buys 8.7M Shares in ATAI Life Sciences at $2.19/Share - AInvest
Here's Why atai Life Sciences (ATAI) Is a Great 'Buy the Bottom' Stock Now - Zacks Investment Research
What are Atai Life Sciences N.V.’s recent SEC filings showingTrade Entry Report & Low Risk Entry Point Guides - 선데이타임즈
Institutional Tools Highlight Unusual Flow in Atai Life Sciences N.V.Market Growth Review & Technical Confirmation Alerts - theviewers.co.kr
Atai Life Sciences shares rise 1.50% premarket after reporting Q2 earnings results. - AInvest
Atai Life Sciences N.V. Nearing Breakout Level After BounceEarnings Miss & Daily Growth Stock Investment Tips - metal.it
Is Atai Life Sciences N.V. the Top Chart Pick This Week2025 Stock Rankings & AI Powered Market Entry Strategies - beatles.ru
Atai Life Sciences Reports Q2 2025 Financial Results - TipRanks
Atai Life Sciences shares fall 1.50% after-hours following earnings report. - AInvest
Atai Life Sciences N.V. Facing Inflection Point in Trend AnalysisVolume Spike & Safe Investment Capital Preservation Plans - newsyoung.net
Atai Life Sciences Revenue Jumps 163% - The Motley Fool
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates - TradingView
Earnings Flash (ATAI) ATAI Life Sciences N.V. Reports Q2 Revenue $719,000 - MarketScreener
Earnings Flash (ATAI) Atai Life Sciences Posts Q2 Net Loss $0.14 a Share, vs. FactSet Est of $0.11 Loss - MarketScreener
Atai Life Sciences N.V. Bounces Off Moving Average SupportConservative Long Term Growth Plans Under Review - metal.it
Maxim Group Reiterates a Buy Rating on Atai Life Sciences (ATAI) With a $10 PT - Insider Monkey
How volatile is Atai Life Sciences N.V. stock compared to the marketAchieve consistent profits with expert advice - Jammu Links News
Atai Life Sciences N.V. Stock Analysis and ForecastFree Stock Market Return Analysis - Jammu Links News
What are analysts’ price targets for Atai Life Sciences N.V. in the next 12 monthsBoost your returns with professional guidance - Jammu Links News
How many analysts rate Atai Life Sciences N.V. as a “Buy”Dynamic profit expansion - Jammu Links News
What are the latest earnings results for Atai Life Sciences N.V.Maximize your gains with professional insights - Jammu Links News
What drives Atai Life Sciences N.V. stock priceGet timely advice on market trends - Jammu Links News
Does Atai Life Sciences N.V. stock perform well during market downturnsTrack top-performing stocks effortlessly - Jammu Links News
How does Atai Life Sciences N.V. generate profit in a changing economyFree Trend-Following Techniques - Jammu Links News
What is the risk reward ratio of investing in Atai Life Sciences N.V. stockDiscover breakthrough stocks with expert help - jammulinksnews.com
How does Atai Life Sciences N.V. compare to its industry peersSky-high return potential - Jammu Links News
H.C. Wainwright Lifts PT on Atai Life Sciences (ATAI) to $15 From $10 - Insider Monkey
AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal - Bloomberg.com
H.C. Wainwright raises atai Life Sciences stock price target to $15 on BPL-003 potential - Investing.com Nigeria
This IonQ Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
Published on: 2025-07-30 03:07:04 - metal.it
What makes Atai Life Sciences N.V. stock price move sharplySwing Setup With Technical Confirmation Explained - metal.it
This Atai Life Sciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - 富途牛牛
How did ATAI's revenue and expenses shift in Q4 2024? - AInvest
Oppenheimer initiates coverage on ATAI Life Sciences with Outperform rating, $14 PT. - AInvest
Oppenheimer initiates atai Life Sciences stock with Outperform rating By Investing.com - Investing.com Nigeria
Oppenheimer initiates atai Life Sciences stock with Outperform rating - Investing.com
Published on: 2025-07-29 09:29:36 - metal.it
Oppenheimer Initiates ATAI Life Sciences N.V at Outperform With $14 Price Target - MarketScreener
Atai: Inidascamine Trial Failure Doesn't Matter In Main Psychedelic Pipeline Focus (ATAI) - Seeking Alpha
ATAI Life Sciences Surges Amidst Market Uncertainty - StocksToTrade
Why Is ATAI Life Sciences Stock Trading Lower On Monday? - inkl
Published on: 2025-07-28 17:17:36 - beatles.ru
ATAI Life Sciences (ATAI) Stock Plunge on Trial Failure News - Yahoo Finance
ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session - 富途牛牛
Why Celcuity Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Nucor, Waste Management And 3 Stocks To Watch Heading Into Monday - Benzinga
What is Atai Life Sciences N.V. company’s growth strategyGet insider insights into market trends - Jammu Links News
What are Atai Life Sciences N.V. company’s key revenue driversExceptional stock performance - Jammu Links News
Why Atai Life Sciences N.V. stock attracts strong analyst attentionFree Access to Community - metal.it
Atai Life Sciences (ATAI) Shares Drop 12% After Schizophrenia Dr - GuruFocus
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):